not much to describe here.
I will just give it a try with a tight stop-loss.
expecting it to fill the gap.
the drop back in dec happened because one of its clinical trials did not succeed.
but they still work on others.
I will just give it a try with a tight stop-loss.
expecting it to fill the gap.
the drop back in dec happened because one of its clinical trials did not succeed.
but they still work on others.
profit can be taken, +50% is not bad at all.
but I will wait for more.